Obesity and related risk of myeloproliferative neoplasms among Israeli adolescents
Abstract
Objective: Obesity has been associated with various malignancies, but a clear association between overweight and myeloproliferative neoplasms (MPN) has not been established.Methods: This study assessed the association between adolescent obesity and future risk for MPN. Data on 2,516,256 Israeli adolescents, who underwent a compulsory general health examination at ages 16 to 19, between 1967 and 2011, were linked to the National Cancer Registry in this nationwide, population‐based cohort study. Cox proportional hazards models were used to estimate the hazard ratio (HR) for MPN associated with BMI measured at adolescence.Results: The mean follow‐up of 19.86 ± 12.15 years reflected 49,977,521 person years, during which 433 examinees developed MPN, primarily chronic myelogenous leukemia, polycythemia vera, and essential thrombocythemia. Obesity (BMI ≥ 95th percentile) in adolescence significantly predicted increased risk of MPN with HR (adjusted for sex) of 1.81 (95% confidence interval 1.13‐2.92,P = 0.014).Conclusions: Adolescent obesity might be related to an increased incidence of myeloproliferative neoplasms.Keywords
This publication has 18 references indexed in Scilit:
- The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European CountriesLeukemia, 2015
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a reviewNutrition Journal, 2014
- Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European UnionEuropean Journal of Haematology, 2014
- Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Women's Health Study cohortInternational Journal of Cancer, 2013
- Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinibCancer Letters, 2013
- Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasmsAmerican Journal of Hematology, 2011
- Obesity and CancerThe Oncologist, 2010
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasmsNature Genetics, 2009
- Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in SwedenBlood, 2008
- Stability of variables associated with the metabolic syndrome from adolescence to adulthood: The Aerobics Center Longitudinal StudyAmerican Journal of Human Biology, 2004